208 related articles for article (PubMed ID: 18187200)
1. Cyclic tetranuclear half-sandwich ruthenium(II) complexes with 4,7-phenanthroline and hydroxo bridges: crystal structure, solution behaviour and binding to nucleosides.
Galindo MA; Quirós M; Romero MA; Navarro JA
J Inorg Biochem; 2008; 102(5-6):1025-32. PubMed ID: 18187200
[TBL] [Abstract][Full Text] [Related]
2. meso-[{Ru(phen)2}2(mu-HAT)]4+: a high-affinity DNA hairpin probe {HAT = 1,4,5,8,9,12-hexaazatriphenylene; phen = 1,10-phenanthroline}.
Smith JA; Morgan JL; Turley AG; Collins JG; Keene FR
Dalton Trans; 2006 Jul; (26):3179-87. PubMed ID: 16802035
[TBL] [Abstract][Full Text] [Related]
3. Tetranuclear coordination assemblies based on half-sandwich ruthenium(II) complexes: noncovalent binding to DNA and cytotoxicity.
Linares F; Galindo MA; Galli S; Romero MA; Navarro JA; Barea E
Inorg Chem; 2009 Aug; 48(15):7413-20. PubMed ID: 19586019
[TBL] [Abstract][Full Text] [Related]
4. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
[TBL] [Abstract][Full Text] [Related]
5. Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.
Chen H; Parkinson JA; Morris RE; Sadler PJ
J Am Chem Soc; 2003 Jan; 125(1):173-86. PubMed ID: 12515520
[TBL] [Abstract][Full Text] [Related]
6. Novel half-sandwich Ru(II)-hydroxamate complexes: synthesis, characterization and equilibrium study in aqueous solution.
Buglyó P; Farkas E
Dalton Trans; 2009 Oct; (38):8063-70. PubMed ID: 19771370
[TBL] [Abstract][Full Text] [Related]
7. Interaction studies of DNA binding of ruthenium(II) mixed-ligand complexes: [Ru(phen)2(dtmi)]2+ and [Ru(phen)2(dtni)]2+.
Liu YJ; Wei XY; Wu FH; Mei WJ; He LX
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):171-6. PubMed ID: 17825604
[TBL] [Abstract][Full Text] [Related]
8. Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.
Wang F; Xu J; Habtemariam A; Bella J; Sadler PJ
J Am Chem Soc; 2005 Dec; 127(50):17734-43. PubMed ID: 16351102
[TBL] [Abstract][Full Text] [Related]
9. Dinuclear ruthenium(ii) complexes with flexible bridges as non-duplex DNA binding agents.
Morgan JL; Spillane CB; Smith JA; Buck DP; Collins JG; Keene FR
Dalton Trans; 2007 Oct; (38):4333-42. PubMed ID: 17893823
[TBL] [Abstract][Full Text] [Related]
10. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
Peacock AF; Parsons S; Sadler PJ
J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies.
Tan LF; Wang F; Chao H; Zhou YF; Weng C
J Inorg Biochem; 2007 Apr; 101(4):700-8. PubMed ID: 17316812
[TBL] [Abstract][Full Text] [Related]
12. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
[TBL] [Abstract][Full Text] [Related]
13. Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.
Melchart M; Habtemariam A; Parsons S; Sadler PJ
J Inorg Biochem; 2007 Nov; 101(11-12):1903-12. PubMed ID: 17582501
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, DNA-binding and photocleavage studies of [Ru(bpy)2(PPIP)]2+ and [Ru(phen)2(PPIP)]2+.
Tan LF; Chao H; Li H; Liu YJ; Sun B; Wei W; Ji LN
J Inorg Biochem; 2005 Feb; 99(2):513-20. PubMed ID: 15621284
[TBL] [Abstract][Full Text] [Related]
15. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
[TBL] [Abstract][Full Text] [Related]
16. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity.
Mulyana Y; Weber DK; Buck DP; Motti CA; Collins JG; Keene FR
Dalton Trans; 2011 Feb; 40(7):1510-23. PubMed ID: 21218244
[TBL] [Abstract][Full Text] [Related]
17. Mononucleotide recognition by cyclic trinuclear palladium(II) complexes containing 4,7-phenanthroline N,N bridges.
Galindo MA; Navarro JA; Romero MA; Quirós M
Dalton Trans; 2004 May; (10):1563-6. PubMed ID: 15252605
[TBL] [Abstract][Full Text] [Related]
18. Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study.
Bíró L; Farkas E; Buglyó P
Dalton Trans; 2012 Jan; 41(1):285-91. PubMed ID: 22051630
[TBL] [Abstract][Full Text] [Related]
19. Structural and spectroscopic evidence for the formation of trinuclear and tetranuclear vanadium(III)/carboxylate complexes of acetate and related derivatives in aqueous solution.
Mukherjee R; Dougan BA; Fry FH; Bunge SD; Ziegler CJ; Brasch NE
Inorg Chem; 2007 Mar; 46(5):1575-85. PubMed ID: 17279741
[TBL] [Abstract][Full Text] [Related]
20. Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes.
Fernández R; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Chemistry; 2004 Oct; 10(20):5173-9. PubMed ID: 15372674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
